Numerical optimization of microfluidic biosensor detection time for the SARS-CoV-2 using the Taguchi method.

The performance of microfluidic biosensor of the SARS-Cov-2 was numerically analyzed through finite element method. The calculation results have been validated with comparison with experimental data reported in the literature. The novelty of this study is the use of the Taguchi method in the optimization analysis, and an L8(2) orthogonal table of five critical parameters-Reynolds number (), Damköhler number (), relative adsorption capacity (), equilibrium dissociation constant (), and Schmidt number (), with two levels was designed.

Taguchi optimization of integrated flow microfluidic biosensor for COVID-19 detection.

In this research, Taguchi's method was employed to optimize the performance of a microfluidic biosensor with an integrated flow confinement for rapid detection of the SARS-CoV-2. The finite element method was used to solve the physical model which has been first validated by comparison with experimental results. The novelty of this study is the use of the Taguchi approach in the optimization analysis.

Assessment of premature ventricular beats in athletes.

Introduction: Premature ventricular complexes (PVC) are generally considered as a benign electrocardiographic abnormality in the athletic population. However it may be indicative of underlying heart disease which may increase the risk of sudden death. This implies the need for cardiological evaluation before indicating the ability to practice competitive sports.

A Series of Octahedral First-Row Transition-Metal Ion Complexes Templated by Wells-Dawson Polyoxometalates: Synthesis, Crystal Structure, Spectroscopic, and Thermal Characterizations, and Electrochemical Properties.

Three Wells-Dawson polyoxotungstates-based hybrid compounds of general formula [M(CHNO)][{M(CHNO)}(μ-PWO)]· nCHNO· n'HO [with M = Mn (1), Fe (2), Co (3) ; n = 2, 2, 3 and n' = 0, 0, 1, respectively] were synthesized at room temperature by a facile method and characterized by IR and H and P NMR spectroscopy studies, thermogravimetric analysis-differential scanning calorimetry thermal analyses, UV-vis, X-ray diffraction (XRD) powder and single-crystal XRD analyses, and cyclic voltammetry studies. From the X-ray study, it was established that the metal (M = Mn, Fe, Co) is located on an inversion center, being octahedrally coordinated to six dimethylformamide (DMF) molecules to form the complex cation [M(dmf)]. Also, in the dinuclear complex anion [{M(dmf)}(μ-PWO)], the M atoms are coordinated to five DMF molecules through the oxygen atoms, while the sixth coordination site is occupied by a terminal oxygen atom of the Wells-Dawson anion [PWO] that plays the role of a bridging ligand.

Crystal structure of octa-kis-(N,N-di-methyl-formamide-κO)europium(III) tetra-cosa-μ2-oxido-dodeca-oxido-μ12-phosphato-dodeca-molybdate(VI).

In the title salt, [Eu(C3H7NO)8][PMo12O40], the asymmetric unit comprises one α-Keggin-type [PMo12O40](3-) polyoxidometalate anion and one distorted dodeca-hedral [Eu(C3H7NO)8](3+) complex cation. In the crystal, the isolated polyoxidometalate anions are packed into hexa-gonally arranged rows extending parallel to [001]. The complex cations are situated between the rows and are linked to the neighbouring anions through weak C-H⋯O hydrogen-bonding inter-actions, leading to the formation of a three-dimensional network structure.

Crystal structure of hexa-kis-(di-methyl-formamide-κO)manganese(II) deca-kis-(di-methyl-formamide)-1κ(5) O,2κ(5) O-[μ-octa-deca-tungstodiphosphato(V)-κO:κO']dimanganate(II) di-methyl-formamide disolvate.

The crystal structure of the title compound, [Mn(C3H7NO)6][{Mn(C3H7NO)5}2(μ-P2W18O62)]·2C3H7NO, reveals that the Wells-Dawson-type polyanion [P2W18O62](6-), through terminal O atoms from the belts, bridges two Mn(II) octa-hedral complexes. In the complex anion [{Mn(dmf)5}2(μ-P2W18O62)](2-), located around a twofold rotation axis, the Mn(II) ions are coordinated by five O atoms from di-methyl-formamide (dmf) ligands and to a terminal O atom from the [P2W18O62](6-) polyanion. Another Mn(II) ion, located on an inversion centre, is coordinated by six O atoms from the dmf ligands and forms the [Mn(dmf)6](2+) cation.

Correction: Single-molecule magnet behaviour in polynuclear assembly of trivalent cerium ions with polyoxomolybdates.

Correction for 'Single-molecule magnet behaviour in polynuclear assembly of trivalent cerium ions with polyoxomolybdates' by A. Ben Khélifa, et al., Dalton Trans.

Single-molecule magnet behaviour in polynuclear assembly of trivalent cerium ions with polyoxomolybdates.

An isopolyoxomolybdate-based POM is coordinated to trivalent cerium ions to afford a hybrid complex namely, [Ce(dmso)8][Ce(η2-NO3)2(dmso)4(α-Mo8O26)0.5][Mo6O19]. The original electrostatic environment created around the Ce(III) by its coordination to the isopolyoxomolybdate core induces complex single-molecule magnet behavior.

Di-chlorido-(5,10,15,20-tetra-phenyl-porphyrinato-κ(4) N)anti-mony(V) hexa-chlorido-anti-monate(V).

The asymmetric unit of the title compound, [Sb(C44H28N4)Cl2][SbCl6], consists of one half of an anti-mony(V) tetra-phenyl-porphyrin complex cation and one half of an hexa-chlorido-anti-monate(V) anion. In the complex cation, the Sb(V) atom lies on an inversion center and is octa-hedrally coordinated by four N atoms from a macrocyclic tetra-phenyl-porphyrinate ligand and two chloride ions. The complex cation has approximately a planar core with a maximum deviation of 0.

3,3'-Bis(chloro-meth-yl)-4,4'-dieth-oxy-1,1'-biphen-yl.

The asymmetric unit of the title compound, C18H20Cl2O2, consists of a half-mol-ecule, the other half being generated by an inversion center, located at the mid-point of the benzene-benzene bond. Except for the two Cl atoms, all other atoms of the compound are nearly coplanar, with the atomic displacements from the mol-ecular mean plane ranging from 0.0037 (19) to 0.

(5,10,15,20-Tetra-phenyl-porphyrinato-κ(4) N)zinc-18-crown-6 (1/1).

In the title compound, [Zn(C44H28N4)]·C12H24O6, the Zn(II) ion lies on an inversion center and the asymmetric unit contains one half of a Zn(TPP) complex (TPP = 5,10,15,20-tetra-phenyl-porphyrin dianion) and one half of a centrosymmetric 18-crown-6 mol-ecule. The Zn(TPP) complex exhibits a nearly planar conformation of the porphyrin core [maximum deviation = 0.106 (2) Å] with an average Zn-N distance of 2.

Aqua-(4-cyano-pyridine-κN (4))(5,10,15,20-tetra-phenyl-porphyrinato-κ(4) N)magnesium.

In the title complex, [Mg(C44H28N4)(C6H4N2)(H2O)], the Mg(2+) cation is octa-hedrally coordinated and lies on an inversion center with the axially located 4-cyano-pyridine and aqua ligands exhibiting 50% substitutional disorder. The cyano-bound 4-cyano-pyridine mol-ecule also is disordered across the inversion centre. The four N atoms of the pyrrole rings of the dianionic 5,10,15,20-tetra-phenyl-porphyrin ligand occupy the equatorial sites of the octa-hedron [Mg-N = 2.

Di-μ-azido-bis-(μ-1,4,7,10,13,16-hexa-oxacyclo-octa-deca-ne)bis-(5,10,15,20-tetra-phenyl-porphyrinato)dicadmium-disodium.

The asymmetric unit of the title compound, [Cd2Na2(N3)2(C44H28N4)2(C12H24O6)2], consists of one half of the dimeric complex; the tetra-nuclear mol-ecule lies about an inversion centre. The Cd(II) atom is coordinated by the four pyrrole N atoms of the 5,10,15,20-tetra-phenyl-porphyrinate ligand and one N atom of the axial azide ligand in a square-pyramidal geometry. The azide group is also linked to the Na(I) atom, which is surrounded by one 18-crown-6 molecule and additionally bonded to a second 18-crown-6 molecule trans to the azide group.

Diaqua-(5,10,15,20-tetra-phenyl-porphyrinato-κ(4)N)magnesium-18-crown-6 (1/1).

In the title compound, [Mg(C(44)H(28)N(4))(H(2)O)(2)]·C(12)H(24)O(6), the Mg(II) cation lies on an inversion center and is octa-hedrally coordinated by the four N atoms of the deprotonated tetra-phenyl-porphyrin (TPP) ligand and by two water mol-ecules. The asymmetric unit contains one half of the [Mg(TPP)(H(2)O)(2)] complex and one half of an 18-crown-6 mol-ecule. The average equatorial magnesium-pyrrole N atom distance (Mg-N(p)) is 2.

(2.2.2-Cryptand)potassium bis-(cyanato-κN)(5,10,15,20-tetra-phenyl-por-phy-rin-ato-κ(4)N)cobaltate(III) chloro-benzene hemisolvate.

In the title compound, [K(C(18)H(36)N(2)O(6))][Co(NCO)(2)(C(44)H(28)N(4))]·0.5C(6)H(5)Cl or [K(2,2,2-crypt)(+)][Co(III)(NCO)(2)(TPP)(-)]·0.5C(6)H(5)Cl, the Co(III) ion is octa-hedrally coordin-ated by two axial N-bonded NCO(-) anions and four pyrrole N atoms of the porphyrin.

1-Benz-yloxy-2,5-bis-(chloro-meth-yl)-4-meth-oxy-benzene.

In the title compound, C(16)H(16)Cl(2)O(2), the dihedral angle between the two rings is 52.65 (10)°. The two Cl atoms are trans to one another being displaced by 1.

Octa-kis(dimethyl sulfoxide-κO)cerium(III) μ(6)-oxido-dodeca-μ(2)-oxido-hexa-oxidohexa-molybdate(VI) dimethyl sulfoxide tetrasolvate.

The title complex, [Ce(C(2)H(6)OS)(8)](2)[Mo(6)O(19)](3)·4C(2)H(6)OS, was obtained as a byproduct of the reaction of [(C(4)H(9))(4)N](2)[Mo(6)O(19)] with Ce(NO(3))(3)·6H(2)O and phthalic acid in dimethyl-sulfoxide solution. The asymmetric unit consists of a complex [Ce(C(2)H(6)OS)(8)](3+) cation, one and a half of the Lindqvist-type [Mo(6)O(19)](2-) polyanions and two dimethyl-sulfoxide solvent mol-ecules; the half polyanion lies on an inversion center. The Ce(3+) ion is coordinated by eight dimethyl-sulfoxide ligands through the O atoms in the form of a distorted square antiprism.

Dichlorido(5,10,15,20-tetra-phenyl-porphyrinato-κ(4)N)anti-mony(V) hemi{di-μ-chlorido-bis-[trichloridoanti-monate(III)]} dichloro-methane monosolvate.

The asymmetric unit of the title complex, [Sb(C(44)H(28)N(4))Cl(2)][Sb(2)Cl(8)](0.5)·CH(2)Cl(2), is composed of a Sb(V) complex cation wherein the Sb atom is hexa-coordinated by four N atoms of the pyrrole rings of the tetra-phenyl-porphyrinate (TPP) ligands and two chloride ions, a half di-μ-chlorido-bis-[trichloridoanti-monate(III)] counter-anion and a dichloro-methane solvent mol-ecule. In the cation, the average Sb-N distance is 2.

Substitutional disorder in bis-[(cyanato-κO)/hydroxido(0.5/0.5)](5,10,15,20-tetra-phenyl-porphyrinato-κN)tin(IV).

The title complex, [Sn(IV)(C(44)H(28)N(4))(CNO)(OH)], exhibits substitutional disorder of the OH(-) and OCN(-) axial ligands. Thus, the cyanato-O ligand and the hydroxyl group bonded to the central Sn(IV) atom share statistically the axial position. The Sn(IV) ion is hexa-coordinated by the four N atoms of the pyrrole rings of the tetra-phenyl-porphyrin (TPP) and the O atoms of the two disordered OCN(-) and OH(-) axial ligands.

Tri-μ-oxido-bis-[(5,10,15,20-tetra-phenyl-porphyrinato-κN)niobium(V)].

In the title dinuclear Nb(V) compound, [Nb(2)(C(44)H(28)N(4))(2)O(3)], each Nb atom is seven-coordinated with three bridging O atoms and four N atoms from a chelating tetra-phenyl-porphyrinate anion. The Nb-O bond lengths range from 1.757 (6) to 2.

Chlorido{5,10,15,20-tetra-kis-[2-(2,2-dimethyl-propanamido)-phen-yl]porphyrinato-κN,N',N'',N'''}iron(III) chloro-benzene hemisolvate monohydrate.

In the title complex, [Fe(C(64)H(64)N(8)O(4))Cl]·0.5C(6)H(5)Cl·H(2)O, the equatorial iron-pyrrole N atom distance (Fe-N(p)) is 2.065 (2) Å and the axial Fe-Cl distance is 2.

(5,10,15,20-Tetra-phenyl-porphyrinato-κN)cobalt(II)-18-crown-6 (1/1).

The asymmetric unit of the title compound, [Co(C(44)H(28)N(4))]·C(12)H(24)O(6), contains one half of a Co(II)(TPP) (TPP is tetra-phenyl-porphyrin) complex and one half of an 18-crown-6 mol-ecule of crystallization, both lying on inversion centers. The Co(II)(TPP) complex exhibits a nearly planar conformation of the porphyrinate core [maximum deviation = 0.069 (2) Å] with an average Co-N distance of 1.

(Cryptand-222)potassium(+) (hydrogensulfido)[5,10,15,20-tetra-kis(2-pival-amido-phen-yl)porphyrinato]ferrate(II).

As part of a systematic investigation for a number of Fe(II) porphyrin complexes used as biomimetic models for cytochrome P450, crystals of the title compound, [K(C(18)H(36)N(2)O(6))][Fe(II)(C(64)H(64)N(8)O(4))(HS)], were prepared. The compound exhibits a non-planar conformation with major ruffling and saddling distortions. The average equatorial iron-pyrrole N atom [Fe-N(p) = 2.

[Evaluation of plasmatic homocysteine determination by gas chromatography-mass spectrometry].

Total plasma homocysteine emerged in the past few years as an independent risk factor for cardiovascular diseases. This test is now currently prescribed for the diagnosis of unexplained thrombosis in young adults or recurrent thrombosis in patients with arteriopathy. This sulphured amino-acid is an important intermediate in transsulfuration and remethylation pathways of methionine metabolism.

The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs.

A major risk associated with bupivacaine during myocardial ischemia is ventricular fibrillation. We investigated the influence of ropivacaine on cardiac contractility and the propensity to ventricular fibrillation before and after myocardial ischemia in a placebo-controlled pig study. Anesthetized domestic pigs were administered 1 mg.